Key facts
| Price (PPV) | 2,234 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | fampridine |
| Class | Other nervous system drugs |
| ATC code | N07XX07 |
| Manufacturer | SOTHEMA |
| Presentation | Boite de 56 (Soit 4 flacons de 14 ) |
| Nature | Médicament |
| Hospital price | 1,888 MAD |
| Data collected on | 9/8/2026 |
Indications
Fampyra est indiqué pour améliorer la capacité de marche des patients adultes atteints de sclérose en plaques et présentant un handicap à la marche (EDSS 4-7).
Find an open pharmacy
On-call pharmacies near you
About Fampyra 10 mg
Fampyra 10 mg belongs to the other nervous system drugs therapeutic class. In Morocco, this drug is marketed by SOTHEMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Fampyra 10 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Fampyra 10 mg
Answers to common questions from Moroccan patients about this drug.